Next Article in Journal
Sunscreen-Based Photocages for Topical Drugs: A Photophysical and Photochemical Study of A Diclofenac-Avobenzone Dyad
Previous Article in Journal
β-Asarone Inhibits Invasion and EMT in Human Glioma U251 Cells by Suppressing Splicing Factor HnRNP A2/B1
Communication

Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2

1
Institute of Scientific Research and High Technology Services (INDICASAT AIP), PO 0843-01103 City of Panama, Panama
2
Department of Biotechnology, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur 522510, Andhra Pradesh, India
3
Department of Chemistry, University of Texas at San Antonio, San Antonio, TX 78249, USA
*
Author to whom correspondence should be addressed.
Molecules 2018, 23(3), 672; https://doi.org/10.3390/molecules23030672
Received: 19 February 2018 / Revised: 13 March 2018 / Accepted: 15 March 2018 / Published: 16 March 2018
(This article belongs to the Section Chemical Biology)
Dengue virus causes dengue fever, a debilitating disease with an increasing incidence in many tropical and subtropical territories. So far, there are no effective antivirals licensed to treat this virus. Here we describe the synthesis and antiviral activity evaluation of two compounds based on the quinoline scaffold, which has shown potential for the development of molecules with various biological activities. Two of the tested compounds showed dose-dependent inhibition of dengue virus serotype 2 in the low and sub micromolar range. The compounds 1 and 2 were also able to impair the accumulation of the viral envelope glycoprotein in infected cells, while showing no sign of direct virucidal activity and acting possibly through a mechanism involving the early stages of the infection. The results are congruent with previously reported data showing the potential of quinoline derivatives as a promising scaffold for the development of new antivirals against this important virus. View Full-Text
Keywords: dengue virus; quinolines; antiviral dengue virus; quinolines; antiviral
Show Figures

Graphical abstract

MDPI and ACS Style

De la Guardia, C.; Stephens, D.E.; Dang, H.T.; Quijada, M.; Larionov, O.V.; Lleonart, R. Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2. Molecules 2018, 23, 672. https://doi.org/10.3390/molecules23030672

AMA Style

De la Guardia C, Stephens DE, Dang HT, Quijada M, Larionov OV, Lleonart R. Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2. Molecules. 2018; 23(3):672. https://doi.org/10.3390/molecules23030672

Chicago/Turabian Style

De la Guardia, Carolina, David E. Stephens, Hang T. Dang, Mario Quijada, Oleg V. Larionov, and Ricardo Lleonart. 2018. "Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2" Molecules 23, no. 3: 672. https://doi.org/10.3390/molecules23030672

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop